Skip to main content
SpringerLink
Log in

Clinical Haemoperfusion

  • Chapter
Haemodialysis

Part of the book series: New Clinical Applications Nephrology ((NCNG,volume 6))

  • 70 Accesses

Abstract

Haemoperfusion, the direct contact of blood with sorbents within cartridges, has been used as an adjunct to dialysis for uraemia, and in drug intoxication, hepatic encephalopathy and for a variety of other conditions which will be outlined.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Yatzidis, H. (1964). A convenient haemoperfusion micro-apparatus over charcoal for the treatment of endogenous and exogenous intoxications. Its use as an artifical kidney. Proc. Eur. Dial. Transplant. Assoc., 1, 83

    Google Scholar 

  2. Dunea, G. and Kolff, W. J. (1965). Clinical experience with the Yatzidis charcoal artifical kidney. Trans. Am. Soc. Artif. Intern. Organs, 11, 178

    PubMed  CAS  Google Scholar 

  3. Chang, T. M. S. (1966). Semipermeable aqueous microcapsules (artificial cells): with emphasis on experiments in an extracorporeal shunt system. Trans. Am. Soc. Artif. Intern. Organs, 12, 13

    PubMed  CAS  Google Scholar 

  4. Denti, E., Luboz, M. P. and Tessore, V. (1975). Adsorption characteristics of cellulose acetate coated charcoals. J. Biomed. Mater. Res., 9, 143

    Article  PubMed  CAS  Google Scholar 

  5. Cornelis, R., Ringoir, S., Mees, L. and Hoste, J. (1980). Behaviour of trace metals during hemoperfusion. Mineral Electrol. Metab., 4, 123

    CAS  Google Scholar 

  6. Hagstam, K. E., Larsson, L. E. and Thysell, H. (1966). Experimental studies on charcoal haemoperfusion in phenobarbital intoxication and uraemia, including histopathologic findings. Acta Med. Scand., 180, 593

    Article  PubMed  CAS  Google Scholar 

  7. Winchester, J. F. (1980). Hemoperfusion in uremia. In Giordano, C. (eds.) Sorbents and Their Clinical Applications, p. 387. (New York: Academic Press Inc.)

    Google Scholar 

  8. Chang, T. M. S. (1978). Microcapsule artificial kidney in replacement of renal function. With emphasis on adsorbent hemoperfusion. In Drukker, W., Parsons, F. M. and Maher, J. F (eds.). Replacement of Renal Function by Dialysis, p. 217. First Edition, (The Hague, Boston, London: Martinus Nijhoff Publishers)

    Google Scholar 

  9. Stefoni, S., Feliciangeli, G., Coli, L. and Bonomini, V. (1979). Evaluation of a new coated charcoal for hemoperfusion in uremia. Int. J. Artif. Organs., 2, 320

    PubMed  CAS  Google Scholar 

  10. Pott, G., Voss, B., Lohmann, J. and Zundorf, P. (1982). Loss of fibronectin in plasma of patients with shock and septicaemia, and after haemoperfusion in patients with severe poisoning. J. Clin. Chem. Clin. Biochem., 20, 333

    PubMed  CAS  Google Scholar 

  11. Winchester, J. F., Ratcliffe, J. G., Carlyle, E. and Kennedy, A. C. (1978). Solute, amino acid, and hormone changes with coated charcoal hemoperfusion in uremia. Kidney Int., 14, 74

    Article  PubMed  CAS  Google Scholar 

  12. Gimson, A. E. S., Langley, P. G., Hughes, R. D, Canalese, J., Mellon, P. G., Williams, R., Woods, H. F. and Weston, M. J. (1980). Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure. Lancet, 1, 173

    Article  PubMed  CAS  Google Scholar 

  13. Muirhead, E. E. and Reid, A. F. (1984). Resin artificial kidney. J. Lab. Clin. Med., 33, 841

    Google Scholar 

  14. Yatzidis, H., Voudiclari, S., Oreopoulos, D., Tsaparas, N., Triantaphyllidis, D., Gavras, C. and Stavroulaki, A. (1965). Treatment of severe barbiturate poisoning. Lancet, 2, 216

    Article  Google Scholar 

  15. Chang, T. M. S., Gonda, A., Dirks, J. H. and Malave, N. (1971). Clinical evaluation of chronic intermittent and short term hemoperfusion in patients with chronic renal failure using semipermeable microcapsules (artificial cells) formed from membrane coated activated charcoal. Trans. Am. Soc. Artif Intern. Organs., 17, 246

    PubMed  CAS  Google Scholar 

  16. Chang, T. M. S. and Migchelsen, M. (1973) Characterization of possible ‘toxic’ metabolites in uremia and hepatic coma based on the clearance spectrum for larger molecules by the ACAC microcapsule artificial kidney. Trans. Am. Soc. Artif. Intern. Organs, 19, 314

    PubMed  CAS  Google Scholar 

  17. Chang, T. M. S., Migchelsen, M., Coffey, J. F. and Stark, R. (1974). Serum middle molecule levels in uremia during long term intermittent hemoperfusion with ACAC (coated charcoal) microcapsule artificial kidney. Trans. Am. Soc. Artif. Intern. Organs., 20, 364

    Google Scholar 

  18. Odaka, M., Hirasawa, H., Kobayashi, H., Ohkawa, M., Soeda, K., Tabata, Y., Soma, M. and Sato, H. (1980). Clinical and fundamental studies of cellulose coated bead-shaped charcoal haemoperfusion in chronic renal failure. In Sideman, S. and Chang, T. M. S. (eds.) Hemoperfusion, Kidney and Liver Support and Detoxification, p. 45. (Washington DC: Hemisphere Publishing Corp.)

    Google Scholar 

  19. Trznadel, K., Luciak, M. and Wyszogrodzka, M. (1981). Effect of haemoperfusion on the left ventricular systolic function in patients with chronic uraemia. Acta Med. Pol., 22, 75

    PubMed  CAS  Google Scholar 

  20. Stefoni, S., Coli, L., Feliciangeli, G., Baldrati, L. and Bonomini, V. (1980). Regular hemoperfusion in regular dialysis treatment. A long-term study. Int. J. Artif. Organs, 3, 348

    PubMed  CAS  Google Scholar 

  21. Otsubo, O., Kuzuhara, K., Simada, Y., Yamauchi, Y., Takahashi, I., Yamada, Y., Otsubo, K. and Inou, T. (1979) Treatment of uraemic peripheral neuritis by direct haemoperfusion with activated charcoal. Proc. Eur. Dial. Transplant Assoc., 16, 731

    PubMed  CAS  Google Scholar 

  22. Chang, T. M. S., Barre, P. and Kuruvilla, S. (1985). Long-term reduced time hemoperfusion-hemodialysis compared to standard dialysis. A preliminary crossover analysis. Trans. Am. Soc. Artif. Intern. Organs, 31, 572

    PubMed  CAS  Google Scholar 

  23. Henderson, I. S. and Kennedy, A. C. (1984). Long-term evaluation of charcoal haemoperfusion combined with dialysis for uraemic patients. In Paul, J. P., Gaylor, J. D. S., Courtney, J. M., Gilchrist, T. (eds.) Biomaterials in Artificial Organs, p. 72. (London and Basingstoke: The Macmillan Press Ltd.)

    Google Scholar 

  24. Bonomini, V., Stefoni, S., Feliciangeli, G., Coli, L., Scolari, M. P., Prandini, R., Casciani, C. U., Taccone Gallucci, Albertazzi, A., Mioli, V., Mastrangelo, F. (1984). Present status of hemoperfusion/hemodialysis in Italy. Appl. Biochem. Biotechnol., 10, 157

    Article  PubMed  CAS  Google Scholar 

  25. Barre, P. E., Gonda, A. and Chang, T. M. S. (1986). Routine clinical applications of hemodialysis-hemoperfusion in chronic renal failure: case reports. Int. J. Artif. Organs, 9, 305

    PubMed  CAS  Google Scholar 

  26. Vale, J. A., Meredith, T. and Buckley, B. (1984). ABC of poisoning. Eliminating poisons. Br. Med. J., 289, 366

    Article  CAS  Google Scholar 

  27. Litovitz, T. and Veltri, J.(1985). 1984 annual report of the American Association of Poison Control Centers. Am. J. Emerg. Med., 3, 423

    Article  PubMed  CAS  Google Scholar 

  28. Henry, J. A. and Cassidy, S. L. (1986). Membrane stabilising ability: A major cause of fatal poisoning. Lancet, 1, 1414

    Article  PubMed  CAS  Google Scholar 

  29. Litovitz, T. L., Normann, S. A. and Veltri, J. C. (1986). 1985 annual report of the American Association of Poison Control Centers National Data Collection System. Am. J. Emerg. Med., 4, 427

    Article  PubMed  CAS  Google Scholar 

  30. Haddad, L. M. (1986). A general approach to poisoning. In Winchester, J. F. (ed.) Office Procedures: Office Management of Poisoning, p. 325. (Philadelphia: Hanley and Belfus Inc.)

    Google Scholar 

  31. Clemmesen, C. and Nilsson, E. (1961). Therapeutic trends in the treatment of barbiturate poisoning: The Scandinavian method. Clin. Pharmacol. Ther., 2, 220

    PubMed  CAS  Google Scholar 

  32. Winchester, J. F., Gelfand, M. C. and Tilstone, W. J. (1978). Hemoperfusion in drug intoxication — Clinical and laboratory aspects. Drug Metab. Rev., 8, 69

    Article  PubMed  CAS  Google Scholar 

  33. Winchester, J. F., Gelfand, M. C., Knepshield, J. H. and Schreiner, G. E. (1977). Dialysis and hemoperfusion of poisons and drugs — Update. Trans. Am. Soc. Artif. Intern. Organs, 23, 762

    PubMed  CAS  Google Scholar 

  34. Rosenbaum, J. L., Kramer, M. S., Raja, R. M., Krug, M. J. and Bolisay, C. G. (1980). Current status of hemoperfusion in toxicology.Clin. Toxicol., 17, 493

    Article  PubMed  CAS  Google Scholar 

  35. Winchester, J. F., Tilstone, W. J., Edwards, R. O., Gilchrist, T. and Kennedy, A. C. (1974). Hemoperfusion for enhanced drug elimination — A kinetic analysis in paracetamol poisoning. Trans. Am. Soc. Artif. Intern. Organs, 20, 358

    Google Scholar 

  36. Pond, S., Rosenberg, J., Benowitz, N. L. and Takki, S. (1979). Pharmacokinetics of haemoperfusion in drug overdose. Clin. Pharmacokinet., 4, 329

    Article  PubMed  CAS  Google Scholar 

  37. Cutler, R. E., Forland, S. C., St John Hammond, P. G. and Evans, R. J. (1987). Extracorporeal removal of drugs and poisons by hemodialysis and hemoperfusion. Ann. Rev. Pharmacol. Toxicol., 27, 169

    Article  CAS  Google Scholar 

  38. Lorch, J. A. and Garella, S. (1979). Hemoperfusion to treat intoxications. Ann. Intern. Med., 91, 301

    PubMed  CAS  Google Scholar 

  39. Uldall, P. R. (1982). Controlled trial of resin hemoperfusion for the treatment of drug overdose at Toronto Western Hospital (TWH). Trans. Am. Soc. Artif. Intern. Organs, 28, 676

    Google Scholar 

  40. Winchester, J. F. (1983). Active methods for detoxification: Oral sorbents, forced diuresis, hemoperfusion, and hemodialysis. In Haddad, L. M. and Winchester, J. F. (eds.) Clinical Management of Poisoning and Drug Overdose, p. 154. (Philadelphia: W. B. Saunders Co.)

    Google Scholar 

  41. Gazzard, B. G., Willson, R. A., Weston, M. J., Thompson, R. and Williams, R., (1974). Charcoal haemoperfusion for paracetamol overdose. Br. J. Clin. Pharmacol., 1, 217

    Google Scholar 

  42. Winchester, J. F., Gelfand, M. C., Helliwell, M., Vale, J. A., Goulding, R. and Schreiner, G. E. (1981). Extracorporeal treatment of salicylate or acetaminophen poisoning — Is there a role? Arch. Intern. Med., 141, 370

    Article  PubMed  CAS  Google Scholar 

  43. Diaz-Buxo, J. A., Farmer, C. D. and Chandler, T. Y. (1978). Hemoperfusion in the treatment of amitriptyline poisoning. Trans. Am. Soc. Artif. Intern. Organs, 24, 699

    PubMed  CAS  Google Scholar 

  44. Trafford, J. A. P., Jones, R. H., Evans, R., Sharp, P., Sharpstone, P. and Cook, J. (1977). Haemoperfusion with R-004 amberlite resin for treating acute poisoning. Br. Med. J., 2, 1453

    Article  PubMed  CAS  Google Scholar 

  45. Crome, P., Braithwaite, R. A., Widdop, B. and Medd, R. K. (1980). Haemoperfusion in clinical and experimental tricyclic antidepressant poisoning. In Sideman, S. and Chang, T. M. S. (eds.) Hemoperfusion, Kidney and Liver Support and Detoxification, p. 301. (Washington DC: Hemisphere Publishing Corp.)

    Google Scholar 

  46. Hoy, W. E., Gibson, T. P., Rivero, A. J., Jain, J. K., Talley, T. T., Bayer, R. M., Montondo, D. F. and Freeman, R. B. (1983). XAD-4 resin hemoperfusion for digitoxic patients with renal failure. Kidney Int., 23, 79

    Article  PubMed  CAS  Google Scholar 

  47. Wenger, T. L., Butler, V. P. Jr, Haber, E. and Smith, T. W. (1985). Treatment of 63 severely digitalis-toxic patients with digoxin specific antibody fragments. J. Am. Coll. Cardiol., 5, (5 Suppl A), 118A

    Article  Google Scholar 

  48. Maini, R. and Winchester, J. F. (1975). Removal of paraquat from blood by haemoperfusion over sorbent materials. Br. Med. J., 3, 281

    Article  PubMed  CAS  Google Scholar 

  49. Mascie-Taylor, B. H., Thompson, J. and Davison, A. M. (1983). Haemoperfusion ineffective for paraquat removal in life-threatening poisoning. Lancet, 1, 1376

    Article  PubMed  CAS  Google Scholar 

  50. Okonek, S., Baldamus, C. A., Hofman, A., Schuster, C. J., Bechstein, P. B. and Zoller, B. (1979). Two survivors of severe paraquat intoxication by ‘continuous hemoperfusion.’ Klin. Wochenshr., 57, 957

    Article  CAS  Google Scholar 

  51. Gelfand, M. C., Winchester, J. F., Knepshield, J. H., Hanson, K. M., Cohan, S. L., Strauch, B. S., Geoly, K. L., Kennedy, A. C. and Schreiner, G. E. (1977). Treatment of severe drug overdose with charcoal hemoperfusion. Trans. Am. Soc. Artif Intern. Organs, 23, 599

    PubMed  CAS  Google Scholar 

  52. Connell, J. M., McGeachie, J. F., Knepil, J., Thomson, A. and Junor, B. (1982). Self-poisoning with sustained-release aminophylline: secondary rise in serum theophylline concentration after charcoal haemoperfusion.Br. Med. J., 284, 943

    Article  CAS  Google Scholar 

  53. Ahlmen, J., Heath, A., Herlitz, H., Kvist, L. and Mellstrand, T. (1984). Treatment of oral theophylline poisoning. Acta Med. Scand., 216, 423

    PubMed  CAS  Google Scholar 

  54. Chang, T. M. S. and Barre, P. (1983). Effect of desferrioxamine on removal of aluminium and iron by coated charcoal haemoperfusion and haemodialysis. Lancet, 2, 1051

    Article  PubMed  CAS  Google Scholar 

  55. Winchester, J. F. (1986). Management of iron overload. Semin. Nephrol., 4, (suppl. 1), 22

    Google Scholar 

  56. Andress, D. L., Maloney, N. A., Endres, D. B. and Sherrard, D. J. (1986). Aluminium-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population. J. Bone Miner. Res., 1, 391

    Article  PubMed  CAS  Google Scholar 

  57. Arieff, A. I. (1985). Aluminium and the pathogenesis of dialysis encephalopathy. Am. J. Kidney Dis., 6, 317

    PubMed  CAS  Google Scholar 

  58. Bregman, H., Gelfand, M. C., Winchester, J. F., Manz, H. J., Knepshield, J. H. and Schreiner, G. E. (1980). Iron overload-associated myopathy in patients on maintenance haemodialysis. A histocompatibility linked disorder. Lancet, 2, 882

    Article  PubMed  CAS  Google Scholar 

  59. Marcus, R. E., Davies, S. C., Bantock, H. M., Underwood, S. R., Walton, S. and Huehns, E. R. (1984). Desferrioxamine to improve cardiac function in iron overloaded patients with thalassemia major. Lancet, 1, 392

    Article  PubMed  CAS  Google Scholar 

  60. Lund, M. E., Banner, W., Clarkson, T. W. and Berlin, M. (1984). Treatment of acute methylmercury ingestion by hemodialysis with n-acetylcysteine (Mucomyst) infusion and 2, 3-dimercaptopropane sulfonate. J. Toxicol Clin. Toxicol., 22, 31

    Article  PubMed  CAS  Google Scholar 

  61. Al-Abassi, A. H., Kostyniak, P. J. and Clarkson, T. W. (1978). An extracorporeal complexing hemodialysis system for the treatment of methylmercury poisoning. III Clinical applications. J. Pharmacol Exp. Ther., 207, 249

    Google Scholar 

  62. Margel, S. (1981). A novel approach for heavy metal poisoning treatment, a model. Mercury poisoning by means of chelating microspheres; hemoperfusion and oral administration. Med. Chem., 24, 1263

    Article  CAS  Google Scholar 

  63. James, J. H., Ziparo, V., Jeppson, B. and Fischer, J. E. (1979). Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: A unified theory of portal-systemic encephalopathy. Lancet, 2, 772

    Article  PubMed  CAS  Google Scholar 

  64. Schafer, D. F. and Jones, E. A. (1982). Hepatic encephalopathy and the gammaaminobutyric-acid neurotransmitter system. Lancet, 1, 18

    Article  PubMed  CAS  Google Scholar 

  65. Chang, T. M. S. (1972). Haemoperfusion over microencapsulated adsorbent in a patient with hepatic coma. Lancet, 2, 1371

    Article  PubMed  CAS  Google Scholar 

  66. Gazzard, B. G., Portmann, B. A., Weston, M. J., Langley, P. G., Murray-Lyon, I. M., Dunlop, E. H., Flax, H., Mellon, P. J., Record, C. O., Ward, M. B. and Williams, R. (1974). Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet, 1, 1301

    Article  PubMed  CAS  Google Scholar 

  67. Silk, D. B. A. and Williams, R. (1980). Sorbents in hepatic failure. In Giordano, C. (ed.) Sorbents and Their Clinical Applications, p. 415. (New York: Academic Press Inc.)

    Google Scholar 

  68. Chang, T. M. S., Lister, C., Chirito, E., O’Keefe, P., Resurrección, E. (1978). Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats. Trans. Am. Soc. Artif. Intern. Organs, 24, 243

    PubMed  CAS  Google Scholar 

  69. Gimson, A. E. S., Braude, S., Mellon, P. J., Canalese, J. and Williams, R. (1982). Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet, 2, 681

    Article  PubMed  CAS  Google Scholar 

  70. Tygstrup, N. and Ranek, L. (1986). Fulminant hepatic failure. Clin. Gastroenterol., 10, 191

    Google Scholar 

  71. Hughes, R. D., Cochrane, A. M. D., Thomson, A. D., Murray-Lyon and Williams, R. (1976). Cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br. J. Exp. Pathol., 57, 348

    PubMed  CAS  Google Scholar 

  72. Seda, H. W. M., Hughes, R. D., Give, C. D. and Williams, R. (1984). Removal of inhibitors of brain Na+ K+ ATPase by haemoperfusion in fulminant hepatic failure. Artif. Organs, 8, 174

    Article  PubMed  CAS  Google Scholar 

  73. Woods, H. F., Weston, M. J., Bunting, S., Moncada, S. and Vane, J. (1980). Prostacyclin eliminates the thrombocytopenia associated with charcoal hemoperfusion and minimizes heparin and fibrinogen consumption. Artif. Organs, 4, 176

    Article  PubMed  CAS  Google Scholar 

  74. Rubin, M. H., Weston, M. J., Bullock, G., Roberts, J., Langley, P. G., White, Y. S. and Williams, R. (1977). Abnormal platelet function and ultrastructure in fulminant hepatic failure. Q. J. Med., 46, 339

    PubMed  CAS  Google Scholar 

  75. Gelfand, M. C., Winchester, J. F., Knepshield, J. H., Cohan, S. I. and Schreiner, G. E. (1978). Reversal of hepatic coma by coated charcoal hemoperfusion: Clinical and biochemical observations, asaio J., 1, 73

    Google Scholar 

  76. Kennedy, H. J., Greaves, M. and Triger, D. R. (1985). Clinical experience with the use of charcoal haemoperfusion: Is prostacyclin required? Life Support Syst., 3, 15

    Google Scholar 

  77. Berk, P. D. (1977). A computer simulation study relating to the treatment of fulminant hepatic failure by hemoperfusion. Proc. Soc. Exp. Biol. Med., 155, 535

    PubMed  CAS  Google Scholar 

  78. Bihari, D., Hughes, R. D., Gimson, A. E. S., Langley, P. G., Ede, R. J., Eder, G. and Williams, R. (1983). Effects of serial resin haemoperfusion in fulminant hepatic failure. Int. J. Artif. Organs, 6, 299

    PubMed  CAS  Google Scholar 

  79. Hughes, R. and Williams, R. (1986). Clinical experience with charcoal and resin hemoperfusion. Semin. Liver Dis., 6, 164

    Article  PubMed  CAS  Google Scholar 

  80. Wagemaker, H. and Cade, R. (1977). The use of hemodialysis in chronic schizophrenia.Am. J. Psychiatr., 134, 684

    PubMed  Google Scholar 

  81. Chang, T. M. S. (1978). Hemoperfusion in chronic schizophrenia. Int. J. Artif. Organs, 1, 253

    PubMed  CAS  Google Scholar 

  82. Nedipil, N., Dieterle, D. and Gurland, H. Y. (1980). Blood purification treatment of schizophrenia. Int. J. Artif. Organs, 3, 76

    Google Scholar 

  83. Schulz, S. C., VanKammen, D. P., Balow, J. E., Flye, N. W. and Bunney, W. E. (1981). Dialysis in schizophrenia: A double blind evaluation. Science, 211, 1066

    Article  PubMed  CAS  Google Scholar 

  84. Nissensson, A. B., Rapaport, M., Gordon, A. and Narins, R. G. (1978). Controlled study demonstrates that psoriasis is not improved by haemodialysis. Kidney Int., 14, 682

    Google Scholar 

  85. Maeda, K., Asada, H., Yamamoto, Y. and Ohta, K. (1980). Psoriasis treatment with direct hemoperfusion. In Sideman, S. and Chang, T. M. S. (eds.) Hemoperfusion, Kidney and Liver Support and Detoxification, p. 349. (Washington DC: Hemisphere Publishing Corp.)

    Google Scholar 

  86. Winchester, J. F., Rahman, A., Bregman, H., Mortensen, L. M., Gelfand, M. C., Schein, P. S. and Schreiner, G. E. (1980). Role of hemoperfusion in anticancer drug removal. In Sideman, S. and Chang, T. M. S. (eds.) Hemoperfusion, Kidney and Liver Support and Detoxification, p. 369. (Washingon DC: Hemisphere Publishing Corp.)

    Google Scholar 

  87. Hande, K. R., Balow, J. E., Draje, J. C., Rosenberg, S. A. and Chabner, B. A. (1977). Methotrexate and hemodialysis. Ann. Intern. Med., 87, 496

    Google Scholar 

  88. Molina, R., Fabian, C. and Cowley, B. Jr (1987). Use of charcoal hemoperfusion to reduce serum methotrexate levels in a patient with acute renal insufficiency. Am. J. Med., 82, 350

    Article  PubMed  CAS  Google Scholar 

  89. Winchester, J. F., Rahman, A., Tilstone, W. J., Kessler, A., Mortensen, L., Schreiner, G. E. and Schein, P. S. (1979). Sorbent removal of adriamycin in vitro and in vivo. Cancer Treat. Rep., 63, 1787

    PubMed  CAS  Google Scholar 

  90. Oldfield, E. H., Dedrick, R. L., Yeager, R. L., Clark, W. C., DeVroom, H. L., Chatterji, D. C. and Doppman, J. L. (1985). Reduced systemic drug exposure by continuous intra-arterial chemotherapy with hemoperfusion of regional venous drainage.J. Neurosurg., 163, 726–732

    Google Scholar 

  91. Terman, D. S. (1980). Extracorporeal immunoadsorbents for extraction of circulation immune reactants. In Giordano, C. (ed.) Sorbents and Their Clinical Applications, p. 470. (New York: Academic Press Inc.)

    Google Scholar 

  92. Terman, D. S., Buffaloe, G., Mattioli, C., Cook, G., Tillquist, R., Sullivan, M. and Ayus, J. C. (1979). Extracorporeal immunoabsorption: Initial experience in human systemic lupus erythematosus. Lancet, 2, 824

    Article  PubMed  CAS  Google Scholar 

  93. Terman, D. S., Yamamoto, T., Mattioli, M., Cook, G., Tillquis, R., Henry, J., Poser and Daskal, Y. (1980). Extensive necrosis of spontaneous canine mammary adenocarcinoma after extracorporeal perfusion over staphylococcus aureus Cowans I. J. Immunol., 124, 795

    PubMed  CAS  Google Scholar 

  94. Terman, D. S. and Bertram, J. H. (1985). Antitumor effects of immobilized protein A and Staphylococcal products: Linkage between toxicity and efficacy and tumoricidal reagents. Eur. J. Cancer Clin. Oncol., 21, 1115

    Article  PubMed  CAS  Google Scholar 

  95. Savin, H., Marcus, L., Margel, S., Ofarim, M. and Ravid, M. (1987). Treatment of adverse digitalis effects of hemoperfusion through columns with antidigoxin antibodies bound to agarose polyacrolein microsphere beads. Am. Heart J., 113, 1078

    Article  PubMed  CAS  Google Scholar 

  96. Chang, T. M. S. and Nicolaev, V. G. (1987). Hemoperfusion, sorbents and immobilized bioreactants. Biomater. Artif. Cells Artif. Organs, 15, (special issue)

    Google Scholar 

  97. Silk, D. B. A. and Williams, R. (1978). Experiences in the treatment of fulminant hepatic failure by conservative therapy, charcoal haemoperfusion and poly-acrylonitrile haemodialysis. Int. J. Artif. Organs, 1, 29

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. F. Winchester
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Aberdeen, UK

    G. R. D. Catto MD, DSc, FRCP (Lond., Edin. and Glasg.) (Professor of Medicine) (Professor of Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Winchester, J.F. (1989). Clinical Haemoperfusion. In: Catto, G.R.D. (eds) Haemodialysis. New Clinical Applications Nephrology, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1257-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1257-1_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7058-4

  • Online ISBN: 978-94-009-1257-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation